Dyne Therapeutics, Inc.

US$18.07As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:DYNHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (1.80%)
Div yield —
ROE (74.56%)
Biotechnology
Beta (5Y) 1.21
PE TTM —
TSR TTM (19.97%)
Mkt cap US$3.386B
ROIC (39.00%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$22
22.02%
299.70%
Hold 4|2|7|2|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.24
0.25
0.23
0.26
12.78%
13.67%
3.79%
13.46%
Revenue$M
363.7
378.5
375.2
375.4
5.87%
6.93%
2.13%
3.34%
Peers (US$3.386B)
Cap (US$)
PE
3.268B
—
3.366B
38.24x
Capital
TTM
5Y
10Y
Leveragex
1.170
1.878
1.664
EBIT/Intx
2.938
0.815
0.689
Own earn%
122.55
(166.91)
(207.40)
Sh yield%
26.57
7.42
10.96
Owners
Insiders/Inst%
8.54
77.01
Short interest%
5.21
SBC / revenue%
1.37
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
0–5
$1 testx
—
Incr. ROIC%
29